Tidal Medical

At Tidal Medical, we've developed the first Smart Incentive Spirometry System, called the InSee. It's designed to help improve lung function and reduce pneumonia risks through smart patient coaching and continuous monitoring. Hospital-acquired pneumonia (HAP) leads to over 140,000 readmissions costing US hospitals over $10B annually. Currently, over 2 million Incentive Spirometers are dispensed annually to help prevent pneumonia. Research has shown that the main challenge of Incentive Spirometry is the lack of patient compliance. And, with no way to quantifiably monitor patient compliance, it’s difficult to identify patients at the highest risk for pneumonia. So, we developed a SMART Incentive Spirometer that can coach the patient to be compliant and empower clinicians' decision-making with objective data.

网站

https://www.breathe-insee.com/

Tidal Medical 的外部链接

所属行业

医疗设备制造业

规模

2-10 人

总部

Berkeley，CA

类型

私人持股

创立

2020